Quick View: $NUVL
- Bullish Crossover on the daily chart, Bullish wave on the hourly chart.
- Some more volume is coming
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−5.32 USD
−260.76 M USD
0.00 USD
47.87 M
About Nuvalent, Inc.
Sector
Industry
CEO
James R. Porter
Website
Headquarters
Cambridge
Founded
2017
IPO date
Jul 29, 2021
IPO offer price
17.00 USD
Identifiers
3
ISINUS6707031075
Nuvalent, Inc. is a clinical stage biopharmaceutical company, which focuses on creating precisely targeted therapies for patients with cancer. Its pipeline includes ROS1 NSCLC, ALK NSCLC and HER2 NSCLC. The company was founded by Matthew D. Shair in January 2017 and is headquartered in Cambridge, MA.
Related stocks
NUVL - your blueprint to H&S patternsHere is the perfect example of the H&S pattern.
Note it.
The ideal entry is after the breakout of the Handle - at the close of the bullish breakout kicker.
Could locate an earlier entry - based on the VWAP and WMA50!
ANd simply keep it along with the trending MA bundle - 21/50/200
Hope this is
Multibagger HEALTH-TECH stock: NUVL
Stage 2 stock
2nd Base Breakout with volume
Pull back with low volume
$NUVL is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $18,45;
stop-loss — $1
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of NUVL is 104.83 USD — it has decreased by −0.84% in the past 24 hours. Watch Nuvalent, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Nuvalent, Inc. stocks are traded under the ticker NUVL.
NUVL stock has risen by 0.75% compared to the previous week, the month change is a −1.98% fall, over the last year Nuvalent, Inc. has showed a 24.46% increase.
We've gathered analysts' opinions on Nuvalent, Inc. future price: according to them, NUVL price has a max estimate of 164.00 USD and a min estimate of 125.00 USD. Watch NUVL chart and read a more detailed Nuvalent, Inc. stock forecast: see what analysts think of Nuvalent, Inc. and suggest that you do with its stocks.
NUVL reached its all-time high on Sep 16, 2024 with the price of 113.51 USD, and its all-time low was 7.09 USD and was reached on May 19, 2022. View more price dynamics on NUVL chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NUVL stock is 2.25% volatile and has beta coefficient of 0.63. Track Nuvalent, Inc. stock price on the chart and check out the list of the most volatile stocks — is Nuvalent, Inc. there?
Today Nuvalent, Inc. has the market capitalization of 7.69 B, it has decreased by −3.23% over the last week.
Yes, you can track Nuvalent, Inc. financials in yearly and quarterly reports right on TradingView.
Nuvalent, Inc. is going to release the next earnings report on Mar 4, 2026. Keep track of upcoming events with our Earnings Calendar.
NUVL earnings for the last quarter are −1.70 USD per share, whereas the estimation was −1.57 USD resulting in a −8.32% surprise. The estimated earnings for the next quarter are −1.48 USD per share. See more details about Nuvalent, Inc. earnings.
Nuvalent, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
NUVL net income for the last quarter is −122.44 M USD, while the quarter before that showed −99.65 M USD of net income which accounts for −22.86% change. Track more Nuvalent, Inc. financial stats to get the full picture.
No, NUVL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 24, 2025, the company has 142 employees. See our rating of the largest employees — is Nuvalent, Inc. on this list?
Like other stocks, NUVL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Nuvalent, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Nuvalent, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Nuvalent, Inc. stock shows the buy signal. See more of Nuvalent, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.